Department of Pediatrics (Prof. Ts. Arakawa), Faculty of Medicine, Tohoku University, Sendai Formiminotransferase activity was estimated on erythrocyte lysates obtained from two cases with the formiminotransferase deficiency syndrome, and was found to be markedly decreased in both the cases as compared with that of controls.
This finding suggested that an estimation of formiminotransferase activity of erythrocyte lysates might be used as a tool for diagnosis of this syndrome. Clinical and biochemical findings of the third case of formiminotransferase deficiency syndrome were described.
Formiminotransferase deficiency syndrome1,2 is diagnosed on the basis of the three criteria consisting of 1) mental retardation, 2) hyperfolic-acidemia and 3) formiminoglutamic aciduria with or without an oral histidine loading.
However, the diagnosis of this syndrome is confirmed when a decreased activity of formiminotransferase is actually demonstrated in liver specimens biopsied from the patients in question.1,2
The present study revealed a decrease in the formiminotransferase activity of erythrocytes from two cases with formiminotransferase deficiency syndrome and suggested the possibility that an estimation of the formiminotransferase activity of erythrocytes might be a useful tool for a diagnosis of this syndrome. METHODS 
AND MATERIALS

Preparation of erythrocyte lysates
The hemolysate was prepared according to Bertino et al.'s method.3 A few ml of blood were taken into a heparinized syringe and erythrocytes were separated by centrifugation, then washed twice with 0.15 M KCl solution. To one volume of the washed erythrocytes were added two volumes of 0.001 M potassium phosphate buffer of pH 8.0. The content was mixed well and then centrifuged. The superna tant fraction was adjusted to be 10.5 g per 100 ml in a hemoglobin concentration by the addition of 0.001 M potassium phosphate buffer of pH 8.0-the hemolysates. 
RESULTS
AND DISCUSSION
As will be seen in Table 1 and Fig. 1 , it was clearly demonstrated that the erythrocyte formiminotransferase activity was markedly decreased in two cases of formiminotransferase deficiency syndrome (Cases 1 and 2) as compared with that in controls (Cases 3-15).
A diagnosis of formiminotransferase deficiency syndrome was established in Cases 1 and 2, which fulfilled such three criteria for the diagnosis as 1) mental retardation, 2) hyperfolic-acidemia and 3) formiminoglutamic aciduria follow ing an oral dose of histidine.1,2 In addition, a marked decrease in formiminotrans ferase activity had been demonstrated' in liver tissues biopsied from Case 1.
Within our literature survey there has been no report dealing with form iminotransferase activity of human erythrocytes. A probable existence of formiminotransferase in human erythrocytes is, however, suspected in view of Bertino et al.'s report3 where the existence of some enzymes related to folate metabolism such as formate activating enzyme, serine hydroxymethylase and N5,10-methenyltetrahydrofolic acid-dehydrogenase in human erythrocytes was described. The third case of formiminotransferase deficiency syndrome U.J., a 9-month-old girl, listed as Case 2 in Table 1 of this paper, was the third case of formiminotransferase deficiency syndrome experienced in our clinic up to the present time.
The patient (U.J.) was born on Nov. 13, 1964 at full term, weighing 2,900g, after an uneventful pregnancy and delivery. She was an only child of healthy and nonconsanguineous parents. The patient was unable to recognize her mother but sat alone when 3 months old, and the mother wondered about a defective vision of her child.
On admission, June 17, 1965, when 7 months old, physical examination revealed a well nourished girl. Bodyweight was 7.5 kg, height 65 cm and Roentgenograms of the chest, bones and skull revealed no abnormality. Peripheral blood pictures, shown in Table 2 , revealed no abnormality. Quantitative estimation of serum protein, sodium, potassium, chloride, urea, lipids and vitamin B12 revealed no abnormality (cf. Table 3) .
Serum folic acid activity, assayed by using L. casei, was found to be 85 my/ml.
Urinary FIGLU following an oral dose of L-histidine-monohydrochloride (0.33 g/kg of bodyweight) was found to be abnormally increased (cf. Table 4 ). Family study: Urinary FIGLU following an oral dose (20 g) of L-histidine monohydrochloride was estimated on both the parents of Case 2 (U.J.) and was found to be slightly increased in only the father (cf. Table 5 ). Serum folate activity (L. easel) of the parents was found to be normal (cf. Table 5 ). Peripheral blood pictures of the parents also showed no abnormality (cf. Table 6 ).
The parents were not consanguineous but consanguinity was found among ancestors of both maternal and paternal sides (cf. Fig. 2 ). Two sisters of maternal grandfather were said to be suffered from 'night blindness', but details of the illness were not clear.
